English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18076/20274 (89%)
造訪人次 : 5356456      線上人數 : 1242
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/31022


    標題: Curcumin analog L3 alleviates diabetic atherosclerosis by multiple effects
    作者: Zheng, Bin
    Yang, Liu
    Wen, Caixia
    Huang, Xiuwang
    Xu, Chenxia
    Lee, Kuan-Han
    Xu, Jianhua
    貢獻者: Fujian Med Univ, Sch Pharm, Dept Pharmacol
    Fuijan Prov Key Lab Nat Med Pharmacol
    Fujian Med Univ, Union Hosp, Dept Pharm
    Fujian Med Univ, Sch Pharm, Dept Med Chem
    Chia Nan Univ Pharm & Sci, Sch Pharm
    關鍵字: L3
    Analog of curcumin
    Diabetic atherosclerosis
    Dyslipidemia
    Hyperglycemia
    日期: 2016-03
    上傳時間: 2018-01-18 11:40:01 (UTC+8)
    出版者: Elsevier Science Bv
    摘要: L3, an analog of curcumin, is a compound isolated from a traditional Chinese medicine Turmeric. In this paper, we aims to explore the efficacy of L3 on diabetic atherosclerosis and the related mechanism. The effect of L3 was studied on glucose and lipid metabolism, antioxidant status, atherosclerosis-related indexes and pathological changes of main organs in the mice model of diabetes induced by streptozotocin and high-fat diet. The results showed that L3 treatment could meliorate dyslipidemia and hyperglycemia, reduce oxidative stress, enhance the activity of antioxidases, increase the nitric oxide level in plasma and aortic arch, decrease the production of reactive oxygen species in pancreas and lectin-like oxidized low-density lipoprotein receptor-1 expression in aortic arch, and meliorate the fatty and atherosclerotic degeneration in aortic arch, thereby preventing the development of diabetes and its complications. These results suggested that L3 can alleviate the diabetic atherosclerosis by multiple effects. This study provided scientific basis for the further research and clinical application of L3. (C) 2016 Elsevier B.V. All rights reserved.
    關聯: European Journal of Pharmacology, v.775, pp.22-34
    顯示於類別:[藥學系(所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML1560檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋